vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Wendy's Co (WEN). Click either name above to swap in a different company.

Wendy's Co is the larger business by last-quarter revenue ($523.5M vs $270.8M, roughly 1.9× HUTCHMED (China) Ltd). Wendy's Co runs the higher net margin — 7.5% vs 0.7%, a 6.8% gap on every dollar of revenue. On growth, Wendy's Co posted the faster year-over-year revenue change (-3.2% vs -16.5%). Wendy's Co produced more free cash flow last quarter ($68.0M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

The Wendy's Company is an American fast food corporation and the holding company for Wendy's and First Kitchen. Originally founded as the Deisel-Wemmer Company, it is headquartered in Dublin, Ohio. The company's principal subsidiary, Wendy's International, is the franchisor of Wendy's restaurants.

HCM vs WEN — Head-to-Head

Bigger by revenue
WEN
WEN
1.9× larger
WEN
$523.5M
$270.8M
HCM
Growing faster (revenue YoY)
WEN
WEN
+13.4% gap
WEN
-3.2%
-16.5%
HCM
Higher net margin
WEN
WEN
6.8% more per $
WEN
7.5%
0.7%
HCM
More free cash flow
WEN
WEN
$64.6M more FCF
WEN
$68.0M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q1 FY2027

Metric
HCM
HCM
WEN
WEN
Revenue
$270.8M
$523.5M
Net Profit
$2.0M
$39.2M
Gross Margin
37.7%
64.1%
Operating Margin
-13.2%
15.9%
Net Margin
0.7%
7.5%
Revenue YoY
-16.5%
-3.2%
Net Profit YoY
-83.6%
72.7%
EPS (diluted)
$0.00
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
WEN
WEN
Q1 26
$523.5M
Q4 25
$270.8M
$543.0M
Q3 25
$549.5M
Q2 25
$277.7M
$560.9M
Q1 25
$324.5M
$523.5M
Q4 24
$574.3M
Q3 24
$566.7M
Q2 24
$305.7M
$570.7M
Net Profit
HCM
HCM
WEN
WEN
Q1 26
$39.2M
Q4 25
$2.0M
$26.5M
Q3 25
$44.3M
Q2 25
$455.0M
$55.1M
Q1 25
$11.9M
$39.2M
Q4 24
$47.5M
Q3 24
$50.2M
Q2 24
$25.8M
$54.6M
Gross Margin
HCM
HCM
WEN
WEN
Q1 26
64.1%
Q4 25
37.7%
62.7%
Q3 25
62.8%
Q2 25
0.1%
65.0%
Q1 25
48.0%
64.1%
Q4 24
65.9%
Q3 24
65.5%
Q2 24
41.1%
65.0%
Operating Margin
HCM
HCM
WEN
WEN
Q1 26
15.9%
Q4 25
-13.2%
11.8%
Q3 25
16.8%
Q2 25
-1.3%
18.6%
Q1 25
-5.0%
15.9%
Q4 24
16.7%
Q3 24
16.7%
Q2 24
-9.0%
17.4%
Net Margin
HCM
HCM
WEN
WEN
Q1 26
7.5%
Q4 25
0.7%
4.9%
Q3 25
8.1%
Q2 25
163.8%
9.8%
Q1 25
3.7%
7.5%
Q4 24
8.3%
Q3 24
8.9%
Q2 24
8.4%
9.6%
EPS (diluted)
HCM
HCM
WEN
WEN
Q1 26
$0.19
Q4 25
$0.00
$0.14
Q3 25
$0.23
Q2 25
$0.52
$0.29
Q1 25
$0.01
$0.19
Q4 24
$0.23
Q3 24
$0.25
Q2 24
$0.03
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
WEN
WEN
Cash + ST InvestmentsLiquidity on hand
$1.4B
$300.8M
Total DebtLower is stronger
$93.2M
$2.8B
Stockholders' EquityBook value
$1.2B
$117.4M
Total Assets
$1.8B
$5.0B
Debt / EquityLower = less leverage
0.08×
23.51×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
WEN
WEN
Q1 26
$300.8M
Q4 25
$1.4B
$300.8M
Q3 25
$291.4M
Q2 25
$1.4B
$281.2M
Q1 25
$836.1M
$335.3M
Q4 24
$450.5M
Q3 24
$482.2M
Q2 24
$802.5M
$465.5M
Total Debt
HCM
HCM
WEN
WEN
Q1 26
$2.8B
Q4 25
$93.2M
$2.8B
Q3 25
$2.7B
Q2 25
$93.4M
$2.7B
Q1 25
$82.8M
$2.7B
Q4 24
$2.7B
Q3 24
Q2 24
$82.1M
Stockholders' Equity
HCM
HCM
WEN
WEN
Q1 26
$117.4M
Q4 25
$1.2B
$117.4M
Q3 25
$109.2M
Q2 25
$1.2B
$112.9M
Q1 25
$759.9M
$130.2M
Q4 24
$259.4M
Q3 24
$259.9M
Q2 24
$740.1M
$273.8M
Total Assets
HCM
HCM
WEN
WEN
Q1 26
$5.0B
Q4 25
$1.8B
$5.0B
Q3 25
$5.0B
Q2 25
$1.8B
$4.9B
Q1 25
$1.3B
$4.9B
Q4 24
$5.0B
Q3 24
$5.1B
Q2 24
$1.3B
$5.1B
Debt / Equity
HCM
HCM
WEN
WEN
Q1 26
23.51×
Q4 25
0.08×
23.51×
Q3 25
24.95×
Q2 25
0.08×
24.18×
Q1 25
0.11×
21.00×
Q4 24
10.57×
Q3 24
Q2 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
WEN
WEN
Operating Cash FlowLast quarter
$8.2M
$85.4M
Free Cash FlowOCF − Capex
$3.4M
$68.0M
FCF MarginFCF / Revenue
1.2%
13.0%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.21×
2.18×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$242.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
WEN
WEN
Q1 26
$85.4M
Q4 25
$8.2M
$69.3M
Q3 25
$129.3M
Q2 25
$-72.9M
$60.6M
Q1 25
$40.3M
$85.4M
Q4 24
$68.6M
Q3 24
$141.2M
Q2 24
$-39.8M
$45.5M
Free Cash Flow
HCM
HCM
WEN
WEN
Q1 26
$68.0M
Q4 25
$3.4M
$31.4M
Q3 25
$104.3M
Q2 25
$-82.2M
$39.2M
Q1 25
$32.5M
$67.7M
Q4 24
$26.6M
Q3 24
$123.3M
Q2 24
$-49.9M
$28.4M
FCF Margin
HCM
HCM
WEN
WEN
Q1 26
13.0%
Q4 25
1.2%
5.8%
Q3 25
19.0%
Q2 25
-29.6%
7.0%
Q1 25
10.0%
12.9%
Q4 24
4.6%
Q3 24
21.8%
Q2 24
-16.3%
5.0%
Capex Intensity
HCM
HCM
WEN
WEN
Q1 26
Q4 25
1.8%
7.0%
Q3 25
4.5%
Q2 25
3.3%
3.8%
Q1 25
2.4%
3.4%
Q4 24
7.3%
Q3 24
3.2%
Q2 24
3.3%
3.0%
Cash Conversion
HCM
HCM
WEN
WEN
Q1 26
2.18×
Q4 25
4.21×
2.62×
Q3 25
2.92×
Q2 25
-0.16×
1.10×
Q1 25
3.38×
2.18×
Q4 24
1.44×
Q3 24
2.81×
Q2 24
-1.54×
0.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons